|
JP6023705B2
(ja)
|
2010-06-23 |
2016-11-09 |
カッパーアールエヌエー，インコーポレイテッド |
ナトリウムチャネル、電位依存性、αサブユニット（ＳＣＮＡ）に対する天然アンチセンス転写物の阻害によるＳＣＮＡ関連疾患の治療
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
WO2012007877A2
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
JP2013532185A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
|
WO2012007883A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
|
|
JP2013532184A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
電位開口型ナトリウムチャネル阻害剤として有用なｎ−スルホニルベンズアミド誘導体
|
|
ES2526981T3
(es)
|
2010-07-12 |
2015-01-19 |
Pfizer Limited |
N-sulfonilbenzamidas como inhibidores de canales de sodio dependientes de voltaje
|
|
KR20130119964A
(ko)
|
2010-12-22 |
2013-11-01 |
퍼듀 퍼머 엘피 |
나트륨 채널 차단제로서의 치환된 피리딘
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
US9073875B2
(en)
|
2012-11-20 |
2015-07-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
|
|
KR102226587B1
(ko)
|
2013-01-31 |
2021-03-11 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 퀴놀린 및 퀴나졸린 아미드
|
|
AU2014212431B2
(en)
*
|
2013-01-31 |
2018-04-05 |
Vertex Pharmaceuticals Incorporated |
Amides as modulators of sodium channels
|
|
PL2953931T3
(pl)
*
|
2013-01-31 |
2017-09-29 |
Vertex Pharmaceuticals Incorporated |
Pirydonoamidy jako modulatory kanałów sodowych
|
|
RU2680401C2
(ru)
*
|
2013-07-19 |
2019-02-21 |
Вертекс Фармасьютикалз Инкорпорейтед |
Сульфонамиды в качестве модуляторов натриевых каналов
|
|
SMT201800521T1
(it)
*
|
2013-12-13 |
2018-11-09 |
Vertex Pharma |
Profarmaci di piridonammidi utili come modulatori di canali del sodio
|
|
JP2017521044A
(ja)
*
|
2014-04-22 |
2017-08-03 |
キュー−ステート バイオサイエンシーズ， インコーポレイテッドＱ−Ｓｔａｔｅ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． |
疼痛及び感覚障害のための化合物の分析
|
|
US10048275B2
(en)
|
2015-03-13 |
2018-08-14 |
Q-State Biosciences, Inc. |
Cardiotoxicity screening methods
|
|
WO2016187543A1
(en)
|
2015-05-21 |
2016-11-24 |
Q-State Biosciences, Inc. |
Optogenetics microscope
|
|
US10441586B2
(en)
|
2015-10-07 |
2019-10-15 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
CRMP2 SUMOylation inhibitors and uses thereof
|
|
KR102384529B1
(ko)
*
|
2016-07-07 |
2022-04-08 |
코르테바 애그리사이언스 엘엘씨 |
4-알콕시-3-(아실 또는 알킬)옥시피콜린아미드의 제조 방법
|
|
WO2018213426A1
(en)
|
2017-05-16 |
2018-11-22 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
WO2019014352A1
(en)
*
|
2017-07-11 |
2019-01-17 |
Vertex Pharmaceuticals Incorporated |
CARBOXAMIDES AS INHIBITORS OF SODIUM CHANNELS
|
|
JP2021512935A
(ja)
|
2018-02-12 |
2021-05-20 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
疼痛を処置する方法
|
|
JP2021530478A
(ja)
*
|
2018-07-09 |
2021-11-11 |
リーバー インスティチュート インコーポレイテッドLieber Institute, Inc. |
ＮａＶ１．８を阻害するためのピリジンカルボキシアミド化合物
|
|
AU2019302534B2
(en)
|
2018-07-09 |
2024-10-03 |
Lieber Institute, Inc. |
Pyridazine compounds for inhibiting NaV1.8
|
|
CN110885328B
(zh)
*
|
2018-09-10 |
2022-08-12 |
成都康弘药业集团股份有限公司 |
作为钠通道阻滞剂的磺酰胺类化合物及其用途
|
|
AU2019372057A1
(en)
|
2018-11-02 |
2021-05-27 |
Merck Sharp & Dohme Llc |
2-amino-N-heteroaryl-nicotinamides as NAV1.8 inhibitors
|
|
US12344595B2
(en)
|
2018-11-02 |
2025-07-01 |
Merck Sharp & Dohme Llc |
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
|
|
WO2020146682A1
(en)
*
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US12440481B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
CN112390745B
(zh)
*
|
2019-08-19 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
|
|
PH12022550584A1
(en)
*
|
2019-09-12 |
2024-03-04 |
Orion Corp |
Pyridine oxynitride, preparation method therefor and use thereof
|
|
PH12022551379A1
(en)
|
2019-12-06 |
2023-05-03 |
Vertex Pharma |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
CN113045487B
(zh)
*
|
2019-12-27 |
2025-01-17 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
EP4168393A1
(en)
|
2020-06-17 |
2023-04-26 |
Merck Sharp & Dohme LLC |
2-oxoimidazolidine-4-carboxamides as nav1.8 inhibitors
|
|
EP4334293A1
(en)
|
2021-05-07 |
2024-03-13 |
Merck Sharp & Dohme LLC |
Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors
|
|
DK4347031T3
(da)
|
2021-06-04 |
2025-12-01 |
Vertex Pharma |
N-(hydroxyalkyl-(hetero)aryl)-tetrahydrofuran-carboxamider som modulatorer af natriumkanaler
|
|
WO2022263498A1
(en)
|
2021-06-15 |
2022-12-22 |
Grünenthal GmbH |
Substituted pyrazole amides
|
|
KR20250069814A
(ko)
*
|
2022-08-12 |
2025-05-20 |
광저우 페르미온 테크놀로지 씨오., 엘티디. |
전압 개폐 나트륨 채널 억제제로서의 화합물
|
|
AR131345A1
(es)
|
2022-12-14 |
2025-03-12 |
Gruenenthal Gmbh |
SULFOXIMINAS COMO INHIBIDORES DE NaV1.8
|
|
EP4385984A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Pyridine-n-oxides as inhibitors of nav1.8
|
|
EP4385980A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Indazoles as inhibitors of nav1.8
|
|
EP4385979A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Multicyclic inhibitors of nav1.8
|
|
CN118324743A
(zh)
*
|
2023-04-19 |
2024-07-12 |
中国科学院上海药物研究所 |
Nav1.8抑制剂及其制备方法和用途
|